The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer
Open accessAbstract
BACKGROUND: The neutrophil-lymphocyte ratio (NLR) has been proposed as an indicator of systemic inflammatory response. Previous findings from small-scale studies revealed conflicting results about its independent prognostic significance with regard to different clinical end points in pancreatic cancer (PC) patients. Therefore, the aim of our study was the external validation of the prognostic significance of NLR in a large cohort of PC patients. METHODS: Data from 371 consecutive PC patients, treated between 2004 and 2010 at a single centre, were evaluated retrospectively. The whole cohort was stratified into two groups according to the treatment modality. Group 1 comprised 261 patients with inoperable PC at diagnosis and group 2 comprised 110 patients with surgically resected PC. Cancer-specific survival (CSS) was assessed using the Kaplan-Meier method. To evaluate the independent prognostic significance of the NLR, the modified Glasgow prognostic score (mGPS) and the platelet-lymphocyte ratio univariate and multivariate Cox regression models were applied. RESULTS: Multivariate analysis identified increased NLR as an independent prognostic factor for inoperable PC patients (hazard ratio (HR)=2.53, confidence interval (CI)=1.64-3.91, P<0.001) and surgically resected PC patients (HR=1.61, CI=1.02-2.53, P=0.039). In inoperable PC patients, the mGPS was associated with poor CSS only in univariate analysis (HR=1.44, CI=1.04-1.98). CONCLUSION: Risk prediction for cancer-related end points using NLR does add independent prognostic information to other well-established prognostic factors in patients with PC, regardless of the undergoing therapeutic modality. Thus, the NLR should be considered for future individual risk assessment in patients with PC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20138 · Cited by 10,679
Roxburgh, C. S., & McMillan, D. C. (2010) · Future Oncology · doi:10.2217/fon.09.136 · Cited by 998
A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1
Pillay, J., Kamp, V. M., van Hoffen, E., Visser, T., Tak, T., Lammers, J.-W., Ulfman, L. H., Leenen, L. P., Pickkers, P., & Koenderman, L. (2012) · Journal of Clinical Investigation · doi:10.1172/jci57990 · Cited by 828
External validation is necessary in prediction research:
Bleeker, S. E., Moll, H. A., Steyerberg, E. W., Donders, A. R. T., Derksen-Lubsen, G., Grobbee, D. E., & Moons, K. G. M. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(03)00207-5 · Cited by 710
Imtiaz, F., Shafique, K., Mirza, S., Ayoob, Z., Vart, P., & Rao, S. (2012) · International Archives of Medicine · doi:10.1186/1755-7682-5-2 · Cited by 645
Proctor, M. J., Morrison, D. S., Talwar, D., Balmer, S. M., O'Reilly, D. S. J., Foulis, A. K., Horgan, P. G., & McMillan, D. C. (2011) · British Journal of Cancer · doi:10.1038/sj.bjc.6606087 · Cited by 531
Pathways connecting inflammation and cancer
Allavena, P., Garlanda, C., Borrello, M. G., Sica, A., & Mantovani, A. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.01.003 · Cited by 437
Teramukai, S., Kitano, T., Kishida, Y., Kawahara, M., Kubota, K., Komuta, K., Minato, K., Mio, T., Fujita, Y., Yonei, T., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.01.023 · Cited by 344
Pichler, M., Hutterer, G. C., Stoeckigt, C., Chromecki, T. F., Stojakovic, T., Golbeck, S., Eberhard, K., Gerger, A., Mannweiler, S., Pummer, K., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.28 · Cited by 275
Self-citationK-ras activation generates an inflammatory response in lung tumors
Ji, H., Houghton, A. M., Mariani, T. J., Perera, S., Kim, C. B., Padera, R., Tonon, G., McNamara, K., Marconcini, L. A., Hezel, A., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209237 · Cited by 271
Differences in Survival by Histologic Type of Pancreatic Cancer
Fesinmeyer, M. D., Austin, M. A., Li, C. I., De Roos, A. J., & Bowen, D. J. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0120 · Cited by 270
Jung, M. R., Park, Y. K., Jeong, O., Seon, J. W., Ryu, S. Y., Kim, D. Y., & Kim, Y. J. (2011) · Journal of Surgical Oncology · doi:10.1002/jso.21986 · Cited by 251
Wang, D.-S., Luo, H.-Y., Qiu, M.-Z., Wang, Z.-Q., Zhang, D.-S., Wang, F.-H., Li, Y.-H., & Xu, R.-H. (2012) · Medical Oncology · doi:10.1007/s12032-012-0226-8 · Cited by 224
Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010
Sharma, C. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i7.867 · Cited by 215
Correlation of Neutrophil to Lymphocyte Ratio With the Presence and Severity of Metabolic Syndrome
Buyukkaya, E., Karakaş, M. F., Karakaş, E., Akçay, A. B., Tanboga, I. H., Kurt, M., & Sen, N. (2014) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029612459675 · Cited by 208
Terradas, R., Grau, S., Blanch, J., Riu, M., Saballs, P., Castells, X., Horcajada, J. P., & Knobel, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042860 · Cited by 163
Imaging of pancreatic cancer: An overview.
Tummala, P., Junaidi, O., & Agarwal, B. (2011) · PubMed · doi:10.3978/j.issn.2078-6891.2011.036 · Cited by 149
Mallappa, S., Sinha, A., Gupta, S., & Chadwick, S. J. D. (2012) · Colorectal Disease · doi:10.1111/codi.12008 · Cited by 147
Jamieson, N. B., Denley, S. M., Logue, J., MacKenzie, D. J., Foulis, A. K., Dickson, E. J., IMRIE, C. W., Carter, R., McKay, C. J., & McMillan, D. C. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1560-3 · Cited by 116
Tsai, J. C. ‐., Sheu, S., Chiu, H., Chung, F., Chang, D., Chen, M., Shin, S., & Lee, Y. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.647 · Cited by 103
Pancreatic Acinar Cell Carcinoma: A Multi-institutional Study
Matos, J. M., Schmidt, C. M., Turrini, O., Agaram, N. P., Niedergethmann, M., Hd, S., Merchant, N. B., Johnson, C. S., Lillemoe, K. D., & Grützmann, R. (2009) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-009-0938-z · Cited by 96
Does gemcitabine-based combination therapy improve the prognosis of unresectable pancreatic cancer?
Sun, C., Ansari, D., Andersson, R., & Wu, D.-Q. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i35.4944 · Cited by 87
Pine, J. K., Fusai, K., Young, R., Sharma, D., Davidson, B. R., Menon, K. V., & Rahman, S. H. (2009) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2008.12.002 · Cited by 73
Cited by
Hu, B., Yang, X.-R., Xu, Y., Sun, Y.-F., Sun, C., Guo, W., Zhang, X., Wang, W.-M., Qiu, S.-J., Zhou, J., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0442 · Cited by 2,493
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Bruni, D., Angell, H. K., & Galon, J. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0285-7 · Cited by 1,586
Bockhorn, M., Uzunoglu, F. G., Adham, M., Imrie, C., Milicevic, M., Sandberg, A. A., Asbun, H. J., Bassi, C., Büchler, M., Charnley, R. M., et al. (2014) · Surgery · doi:10.1016/j.surg.2014.02.001 · Cited by 967
The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis
McAllister, S. S., & Weinberg, R. A. (2014) · Nature Cell Biology · doi:10.1038/ncb3015 · Cited by 966
Qi, Q., Zhuang, L., Shen, Y., Geng, Y., Yu, S., Chen, H., Liu, L., Meng, Z., Wang, P., & Chen, Z. (2016) · Cancer · doi:10.1002/cncr.30057 · Cited by 761
Metadata
- Authors
- Stotz, M., Gerger, A., Eisner, F., Szkandera, J., Loibner, H., L Ress, A., Kornprat, P., A Zoughbi, W., Seggewies, F. S., Lackner, C., Stojakovic, T., Samonigg, H., Hoefler, G., & Pichler, M.
- Venue
- British Journal of Cancer
- Published
- 2013-06-25
- Volume
- 109
- Issue
- 2
- Pages
- 416-421
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W1984052587
- Cited by
- 490
- References
- 25
- FWCI
- 22.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.